Human bronchial-pulmonary proteomics in coronavirus disease 2019 (COVID-19) pandemic: applications and implications

Heng Wee Tan1, Yan-Ming Xu1, Andy T Y Lau1

  • 1Laboratory of Cancer Biology and Epigenetics, Department of Cell Biology and Genetics, Shantou University Medical College, Shantou, People's Republic of China.

Expert Review of Proteomics
|November 23, 2021
PubMed
Abstract

Insights

Human bronchial-pulmonary proteomics is key to understanding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection dynamics and pathogenicity. This research aids in discovering biomarkers and therapeutic targets for coronavirus disease 2019 (COVID-19).

Area of Science:

  • Proteomics
  • COVID-19 Research
  • SARS-CoV-2 Pathogenesis

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), impacting multiple organs with the respiratory system as the primary infection site.
  • Understanding the molecular mechanisms of SARS-CoV-2 infection is critical for developing effective treatments.

Purpose of the Study:

  • To review the application of omics technologies in SARS-CoV-2 research.
  • To specifically examine current knowledge of COVID-19 through the lens of human bronchial-pulmonary proteomics.
  • To identify knowledge gaps addressable by proteomics in COVID-19 research.

Main Methods:

  • Review of existing literature on omics technologies and COVID-19.
  • Focus on human bronchial-pulmonary proteomics data and findings.
  • Analysis of knowledge gaps in the context of proteomic research.

Main Results:

  • Human bronchial-pulmonary proteomics provides crucial insights into SARS-CoV-2 dynamics, tropism, and pathogenicity.
  • Proteomics is vital for identifying potential biomarkers and therapeutic targets for COVID-19.
  • Current research highlights the importance of proteomic analysis in understanding host-pathogen interactions in the lungs.

Conclusions:

  • Human bronchial-pulmonary proteomics is essential for advancing COVID-19 understanding and therapeutic development.
  • Further multi-omics research on lungs and other organs is needed for a comprehensive understanding of COVID-19's impact.

Related Concept Videos

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
8.5K
Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
20.6K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
682
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K